; (B) be updated at least bi-annually; and (C) be publicly available. (c) Requirement The registry under subsection (a) shall, with respect to each drug included on the registry, provide information about the drug’s supply chain, including each step in the supply chain that occurs prior to the drug’s importation into the United States. . 7. Country-of-origin labeling Section 502 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352 ) is amended by adding at the end the following: (ee) If it is a drug and its labeling does not specify the country of origin of each active pharmaceutical ingredient contained in the drug. .